| 发明名称 |
Renal cell carcinoma treatment |
| 摘要 |
Methods for treating treatment-naive as well as treatment-experienced patients having RCC to achieve at least a partial tumor response involving administering a therapeutically effective amount of pegylated interferon-alfa, e.g. , pegylated interferon alfa-2b as monotherapy or in association with a therapeutically effective amount of IL-2 are disclosed.
|
| 申请公布号 |
EP1535623(A1) |
申请公布日期 |
2005.06.01 |
| 申请号 |
EP20050002952 |
申请日期 |
2000.04.06 |
| 申请人 |
SCHERING CORPORATION |
发明人 |
ROSE, ESTHER HELEN;RYBAK, MARY ELLEN |
| 分类号 |
A61K38/21;A61K47/48;A61K9/08;A61K31/513;A61K38/00;A61K47/34;A61P13/12;A61P35/00;(IPC1-7):A61K38/21 |
主分类号 |
A61K38/21 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
